Skip to main content
Shield Therapeutics plc (AIM:STX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11.59
+0.29 (2.57%)
Dec 5, 2025, 4:13 PM GMT+1

Shield Therapeutics Revenue

Shield Therapeutics had revenue of $21.45M USD in the half year ending June 30, 2025, with 472.99% growth. This brings the company's revenue in the last twelve months to $41.50M, up 93.23% year-over-year. In the year 2024, Shield Therapeutics had annual revenue of $32.18M with 145.93% growth.

Revenue (ttm)
$41.50M
Revenue Growth
+93.23%
P/S Ratio
4.03
Revenue / Employee
$658.65K
Employees
63
Market Cap
122.11M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202432.18M19.10M145.93%
Dec 31, 202313.09M7.59M137.95%
Dec 31, 20225.50M3.44M167.35%
Dec 31, 20212.06M-12.12M-85.50%
Dec 31, 202014.18M13.23M1,389.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.24B
GSK plc 32.17B
Haleon 11.02B
Smith & Nephew 4.33B
Convatec Group 1.72B
Hikma Pharmaceuticals 2.35B
HUTCHMED (China) 439.54M
Genus 672.80M
Revenue Rankings

Shield Therapeutics News

More News